ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HOPHF Hemogenyx Pharmaceuticals PLC (PK)

0.04
0.00 (0.00%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 00000000
Operating Income -80k-459k-740k-1.59M-1.46M-2.13M-2.66M-5.53M
Pre Tax Income -80k-471k-2.41M-1.59M-1.49M-2.1M-5.11M-3.99M
Net Income -80k-471k-2.36M-1.54M-1.45M-2.08M-5.1M-3.98M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.001-0.007-0.007-0.004-0.004-0.005-0.005-0.004
EBIT -80k-459k-2.37M-1.59M-1.46M-2.13M-2.66M-5.53M
EBITDA -80k-447k-706k-1.53M-1.36M-2.03M-2.53M-4.97M